3-((1H-1,2,4-Triazol-5-yl)thio)-1-(3,5-dimethylphenyl)pyrrolidine-2,5-dione

Catalog No. :
ACLWUQ745
CAS No. :
364624-08-8
Molecular Formula :
C14H14N4O2S
Molecular Weight :
302.36

IUPAC Name:3-((1H-1,2,4-triazol-5-yl)thio)-1-(3,5-dimethylphenyl)pyrrolidine-2,5-dione

3-((1H-1,2,4-Triazol-5-yl)thio)-1-(3,5-dimethylphenyl)pyrrolidine-2,5-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((1H-1,2,4-Triazol-5-yl)thio)-1-(3,5-dimethylphenyl)pyrrolidine-2,5-dione
IUPAC Name3-((1H-1,2,4-triazol-5-yl)thio)-1-(3,5-dimethylphenyl)pyrrolidine-2,5-dione
Molecular FormulaC14H14N4O2S
Molecular Weight302.36
SMILESO=C(C(SC1=NC=NN1)C2)N(C3=CC(C)=CC(C)=C3)C2=O
InChI KeyZFKWFHMKVZEDEN-UHFFFAOYSA-N
Synonym1-(3,5-dimethylphenyl)-3-(4H-1,2,4-triazol-3-ylsulfanyl)pyrrolidine-2,5-dione;2,5-Pyrrolidinedione, 1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)-;WAY-308264
CAS No.364624-08-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLWUQ745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHUXC356 route compound structure diagram
    ACHUXC3563179-31-5 In Stock
  4. Then
  5. ACLWUQ745 route product structure diagram
    ACLWUQ745364624-08-8
Inquiry

2. ACLWUQ745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHUXC356 route compound structure diagram
    ACHUXC3563179-31-5 In Stock
  4. Then
  5. ACLWUQ745 route product structure diagram
    ACLWUQ745364624-08-8
Inquiry

Comments (0)